Skip to main content
. 2020 Nov 17;7:509. doi: 10.3389/fmed.2020.00509

Table 2.

Baseline characteristics in relation to Ec-SOD activity.

Ec-SOD ≤ 83 U/L (n = 59) Ec-SOD > 83 U/L (n = 74) P-valuea
Age, years 31 (25, 48) 39 (29, 52) 0.022
Female gender, n (%) 45 (76) 49 (66) <0.001
BMI, kg/m2 22 (19, 23) 22 (21, 24) 0.500
BMPR2 mutation 17 (29) 11 (15) 0.521
WHO FC, n (%) <0.001
    Class II 14 (24) 31 (42)
    Class III 35 (59) 36 (49)
    Class IV 10 (17) 7 (9)
Onset to diagnosis, months 18 (6, 33) 34 (7, 60) 0.033
6MWD, metersb 360 (276, 415) 390 (329, 452) 0.008
BNP, pg/ml 387 (158, 529) 319 (147, 488) 0.857
Cu/Zn-SOD, U/ml 146 (110, 213) 148 (120, 213) 0.911
    Mn-SOD, U/ml 46 (34, 90) 39 (29, 52) 0.082
Hemodynamic variables
    HR, bpm 82 (73, 94) 86 (76, 97) 0.409
    mRAP, mmHg 8 (5, 13) 7 (5, 11) 0.631
    mPAP, mmHg 63 (54, 77) 59 (50, 67) 0.048
    PAWP, mmHg 9 (6, 11) 9 (7, 12) 0.453
    CO, L/min 3.5 (3.0, 4.5) 3.6 (2.9, 5.0) 0.410
    CI, L/min/m2 2.3 (1.8, 2.8) 2.2 (1.8, 2.8) 0.792
    PVR, Wood units 16 (12, 22) 14 (9, 17) 0.040
    SVO2, % 58 (53, 62) 61 (54, 68) 0.192

Values are expressed as medians (interquartile range), except for female gender and WHO functional class, which are numbers of patients (%).

a

Comparison between groups with Ec-SOD ≤ 83 U/L and Ec-SOD > 83 U/L.

b

6MWD could be successfully measured in 124 patients.

BMI, body mass index; BMPR 2, bone morphogenetic protein receptor type 2; BNP, brain natriuretic peptide; CI, cardiac index; CO, cardiac output; Cu/Zn-SOD, copper–zinc superoxide dismutase; Ec-SOD, extracellular form of Cu/Zn superoxide dismutase; HR, heart rate; Mn-SOD, manganese superoxide dismutase; mPAP, mean pulmonary arterial pressure; mRAP, mean right atrial pressure; 6MWD, 6-min walking distance; PAWP, pulmonary artery wedge pressure; PVR, pulmonary vascular resistance; SvO2, mixed venous oxygen saturation; WHO FC, World Health Organization functional class.